Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-25 @ 8:34 PM
Study NCT ID:
NCT07285369
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-16
First Post:
2025-11-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)
Sponsor:
Agyany Pharma LTD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-21
First Submit QC Date:
None
Study First Post Date:
2025-12-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-16
Last Update Post Date Type:
ESTIMATED